BIT's 4th Annual World Congress of MolMed-2014
BIT's Upcoming Events


Media Partners
璇存槑: C:\Users\Chen\Desktop\鏂板缓鏂囦欢澶筡logo_g2b.jpg

Scenery of Haikou
  • Nobel Laureate Forum, Keynote Forum and Social Events
  • 7 Chapters Covering Major Hot Fields in Molecular Medicine
  • 20+ Exhibitors Showcasing the Emerging Methodologies and Technologies
  • 50+ Posters for Briefing the Current Molecular Medicine Research
  • 20 Industrialization Project Matchmaking
  • 150 Overseas+ 50 Domestic Molecular Medicine Experts Discuss, Exchange of Experience and Share the Results

BIT鈥檚 3rd Annual Congress of MolMed-2013 (MolMed-2013), successfully held in Hainan International Convention and Exhibition Center on November 13-16, 2013. Totally, there were nearly 200 participants from more than 20 countries and areas have attended the MolMed-2013.
The theme of this conference is "Transform the Top Science and Technology into Productivity". This annual congress comprised 6 paths and 13 tracks following the opening ceremony, including Molecular Medicine: State-of-the-Art and Perspectives, Biomarkers, Molecular Diagnostics, Molecular Medicine and Oncology, Molecular Insights for Disease Advance Therapies, Personalized Medicine鈥tc. More than 200 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the conference. Depending on the warmly support and good suggestions from all of the participants, we are confident in organizing MolMed-2014 which would be better and more successful than MolMed-2013.

  • Bring you information to improve the success of your molecular medicine research
  • Bring yourself up-to-date on current developments and future trends
  • Maximize your knowledge of the latest advances in the molecular medicine areas
  • Do not miss the opportunity of meeting expert speakers representing leading organizations and companies
  • Special Networking Events: Meet and network with the key people working in the industry
  • Build academic and business collaboration

MolMed-2014 provides an ideal platform to showcase your novel technologies and products in China. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibition.
Why Reserve a Booth at MolMed-2014
Meet Face-to-Face with the International Movers
鈥 To Meet with Key Decision Maker around the World
鈥 To Explore Business Opportunities in China and beyond
鈥 To Spotlight Advanced Technologies and Their Scientific and    Commercial Applications
鈥 To Take Advantage of the Conference's Captive Audience    and Networking Opportunities within the Exhibition Hall


Dr. Arieh Warshel,

Distinguished Professor of Chemistry and Biochemistry, Dana and David Dornsife; Chair in Chemistry, University of Southern California, USA
Nobel Prize in Chemistry (2013)


Dr. Dan Shechtman,
Distinguished Professor, Israel Institute of
Technology, Israel
Nobel Prize in Chemistry (2011)


Dr. Ada E. Yonath,

Professor, Weizmann Institute, Israel
Nobel Prize in Chemistry (2009)



Dr. Hartmut Michel,

Professor and Director, Max Planck Institute of
Biophysics, Germany
Nobel Prize in Chemistry (1988)

Dr. Alan Garen,
Professor, Yale University, USA

Dr. Philippe Henon, Professor, Centre Hospitalier de Mulhouse; President and CSO, CellProthera; Director, IRHT, France


Dr. Edward Lanphier, President & CEO, Sangamo BioSciences, Inc., USA


Dr. Carol Isaacson Barash, Editor-in-Chief, journal of Applied and Translational Genomics, Elsevier; Founder & Principal, Helix Health Advisors, USA

Applied & Translational Genomics Call for Paper


Dr. Limin Chen, Professor, Chinese Academy of Medical Sciences, China & University of Toronto, Canada


Dr. Patrice Denefle, Associate Professor, Paris Descartes University; Senior Partner & Co-founder, MedBioMix Partners, France



Dr. Carol Isaacson Barash,
Founder & Principal, Helix Health Advisors, USA

Dr. Limin Chen, Professor, Chinese Academy of Medical Sciences, China & Canada

Dr. Patrice Denefle,
Senior Vice President, Translational Sciences, Ipsen, France

Dr. Edward Lanphier, President & CEO, Sangamo BioSciences, Inc. USA

Dr. Kaiser J. Aziz,
Managing Director, KJ Biomedical Consulting, USA

Dr. Xinhua Ji,
Senior Investigator, National Cancer Institute, USA

Dr. Cha-Mei Tang,President and CEO, Creatv MicroTech, Inc., USA

Dr. Charles J Malemud, Professor, Case Western Reserve University School of Medicine, USA

Dr. Yaron Ilan,
Professor, Hadassah Hebrew University Medical Center, Israel

Dr. Christoph A Merten, Group Leader, European Molecular Biology Laboratory, Germany

Dr. Manfred Dietel, Professor and Director, Charit茅-University Hospital, Germany

Dr. Sudhir Sahasrabudhe,
CEO, Rines Therapeutics, USA

Dr. Anil Kumar Mandal, Professor/Founder, Mandal Diabetes Research Foundation (MDRF), USA

Dr. Yao-Shan Fan, Director, University of Miami Miller School of Medicine, USA

Dr. Dale Christensen, President & Chief Scientific Officer, Oncotide Pharmaceuticals Inc., USA

Dr. Karanis Panagiotis, Professor, Qinghai
Academy of Animal and Veterinary Science,
Qinghai University, China.

Dr. Gregory A. Buck, Professor and Director, Virginia Commonwealth University, USA

Dr. Su-Shing Chen, Professor, University of Florida, USA

Dr. Jianping Xu,
Professor, McMaster University, Canada

Dr. Sunil D. Pandit, Senior Manager, Siemens Healthcare Diagnostics, USA Mr. Michael Murphy, President, Conatus Consulting, Inc., USA

Dr. Xinle Niu,
Technical Support Manager, Thermo Fisher Scientific, USA


Haikou Municipal Government
璇存槑: 璇存槑: Hainan Harvest West Point M.I.C.E. Service Co.,Ltd
Information Research Center of International Talents, SAFEA Foreign Experts Databank of SAFEA-Dalian Experts Subdivision Haikou Convention and Exhibition Bureau BIT Congress Inc.
Foreign Experts Databank of SAFEA-Dalian Biotechnological
and Medical Experts Subdivision
BIT World Travel Service, Inc.